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Glucose transporter (GLUT1) allele (XbaI–) associated with increasing rapidly in the recent years [1]. NIDDM is a
nephropathy in non-insulin-dependent diabetes mellitus. metabolic disorder characterized by chronic hyperglyce-
Background. Although multiple factors contribute to the mia caused by impaired glucose metabolism. Nowadays,initiation and progression of diabetic nephropathy (DN),
most diabetic patients eventually experience one or morehyperglycemia and genetic predisposition are two major com-
of the long-term complications of this chronic disease.ponents implicated in the development of DN. Several pieces
of experimental evidence suggest that glucose transporter Diabetic retinopathy, nephropathy, and cardiovascular
(GLUT1) activity is an important modulator for the cell hyper- disorders are the most conspicuous complications. How-
trophy and extracellular matrix formation of glomerular mes- ever, unlike retinopathy, which eventually affects a ma-angial cells.
jority of the diabetic patients over time, nephropathyMethods. To evaluate the role of the GLUT1 gene mutation
developed in only a limited population of approximatelyin the development of DN in Chinese patients with non-insulin-
dependent diabetes mellitus (NIDDM), the polymorphic XbaI 30 to 40% of the whole group [2, 3]. Such an epidemiolog-
site of GLUT1 gene was analyzed by polymerase chain reaction ical phenomenon suggests that a subset of diabetic indi-
in 124 normal subjects and 131 patients with NIDDM, among
viduals are particularly susceptible to diabetic nephropa-whom 64 were complicated with DN. DN was defined as persis-
thy (DN). Strong familial aggregation of the diseasetent albuminuria with or without impaired renal function with
no known cause of renal disease other than diabetes. suggests that genetic components play a major role as
Results. The frequencies of XbaI (1/2) genotype (75 vs. determinants of susceptibility to the disease. The inher-
44%, P , 0.01) and XbaI (2) allele (44 vs. 29%, P , 0.05) ited defects in the greater part of the common form of
were significantly higher in NIDDM patients with DN than
NIDDM, however, remain to be identified [3, 4]. Diabe-those without nephropathy. There were no significant differ-
tes results from the combined deficiencies of insulin se-ences for GLUT1 genotype and allele frequency between
NIDDM patients without nephropathy and normal subjects. cretion, insulin action, glucose uptake, and utilization.
The presence of the XbaI (2) allele appeared to have a strong Efforts have been made to search for the gene polymor-
association with the development of DN. The odds ratio was phism of these physiological actions. However, even tak-1.915, and the 95% confidence interval was 1.044 to 3.514. In
ing advantage of the recent progress in biotechnology,addition, no strong association was found between GLUT1
population-association studies of several candidate genesgene polymorphism and retinopathy in NIDDM patients.
Conclusion. Our results indicate that the XbaI (2) allele of for the etiology of NIDDM, including the glucose trans-
the GLUT1 gene might be a genetic marker of NIDDM with porter genes glucose transporter-1 (GLUT1) and GLUT2
DN, and this genetic susceptibility is independent of its retinop- [5, 6], the insulin receptor gene [7], the insulin gene [8],athy in Chinese subjects.
the insulin receptor substrate-1 gene [9, 10], and the
glucokinase gene [11], have thus far yielded inconclusive
results.Nephropathy is a major cause of morbidity and mortal-
Glucose transporters are membrane-embedded pro-ity in diabetes mellitus. Non-insulin-dependent diabetes
teins that mediate the uptake of glucose from the sur-mellitus (NIDDM) accounts for approximately 5% of
rounding medium into the cells. Glucose is the main fuelend-stage renal diseases in China, and the frequency is
for most cells, and its uptake is rate limiting for a more
efficient utilization [12, 13]. Immunogold labeling and in
situ hybridization studies showed that glucose transport-Key words: diabetic nephropathy, hyperglycemia, cell hypertrophy,
NIDDM, albuminuria. ers are widely distributed from glomeruli down to the
inner medullary collecting duct in normal kidney [14,Received for publication March 9, 1998
15]. It has been demonstrated that GLUT1 is the mainand in revised form December 18, 1998
Accepted for publication December 18, 1998 transporter of glucose in the glomeruli [15, 16]. As alter-
ations of glomerular mesangial cells constitute the most 1999 by the International Society of Nephrology
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common pathological changes of DN and contribute to
the kidney failure in this disease, we hypothesized that
GLUT1 gene mutation might contribute to the develop-
ment of DN. To evaluate the role of mutation of the
GLUT1 gene in the development of renal damage in
NIDDM, a gene population study was conducted in a
group of Chinese NIDDM patients with or without ne-
phropathy and normal subjects using the XbaI polymor-
phism of the GLUT1 gene.
METHODS
Patients and controls
Glucose transporter-1 gene polymorphism was as-
sessed in 131 patients of NIDDM (83 males and 48 fe-
males, ranging in age from 46 to 71) with or without
nephropathy and 124 nondiabetic control subjects (58
males and 66 females, ranging in age from 36 to 54).
All patients enrolled in this study were diagnosed with
NIDDM according to the criteria based on the World
Health Organization report of 1985. They were recruited
from the patients attending the nephrological clinic, be-
Fig. 1. XbaI polymorphism of human GLUT1 gene detected by PCR-ing hospitalized for a thorough examination. Twenty-
RFLP. Lanes 1 and 2 are the XbaI (1/1) genotype. Lane 3 is the XbaI
four hour urinary albumin excretion (UAE) was mea- (2/2) genotype. Lane 4 is the XbaI (1/2) genotype.
sured for each diabetic patient on three separate occa-
sions during the observation period. Urinary albumin
concentration was measured within 10 days of storage
XbaI restriction fragment length polymorphismat the standard refrigerator temperature. UAE was as-
(RFLP) of the human GLUT1 genesayed by radioimmunoassay. For this study, the defini-
The polymorphic XbaI site is localized in the secondtion of overt albuminuria was an UAE measurement of
intron of the gene by restriction enzyme analysis of a200 mg/min or more. DN was defined as the presence of
human GLUT1 genomic clone. In the mutant form, gua-persistent albuminuria or proteinuria with or without
nine (G) has been transversed to thymine (T) and abol-impaired renal function, with no known cause of renal
ished the recognition site. A 59 primer (TGT GCA ACCdisease other than diabetes. According to this definition,
CAT GAG CTA A) and a 39 primer (CCT GGT CTC64 cases diagnosed as having the complication of DN
ATC TGG ATT CT) were synthesized. A 1.1 kb DNA(40 males and 24 females, ranging in age from 48 to 67),
fragment including the polymorphic XbaI site was ampli-among whom 40 patients underwent renal biopsy, all
fied by polymerase chain reaction (PCR) [6]. After 30showed the histological changes of DN. Cases showing
cycles of amplification consisting of denaturation at 948Cevidence of parenchymatous renal disease other than the
for one minute, annealing at 558C for one minute, exten-DN or urinary tract diseases were excluded from the
sion at 728C for 1.5 minutes, the PCR products werestudy. Eighty-five out of the 120 cases with NIDDM in
digested with XbaI restriction enzyme and electropho-
this group were screened for diabetic retinopathy. Body resed on a 1.2% agarose gel. XbaI RFLP was detected
mass index (BMI) of all of the cases was calculated as by ethidium bromide staining. A 1.1 kb band corre-
weight/height2 (kg/m2). All of the cases and normal con- sponded to the XbaI (2) allele, and a set of 0.9 and 0.2
trol subjects included in this study were of Han nation- kb bands corresponded to the XbaI (1) allele (Fig. 1).
ality.
Statistics
Genomic DNA preparation Allele frequency means the number of occurrences of
DNA was extracted by standard methods from periph- the test allele in the population divided by the total
eral blood monocytes. Genomic DNA suspended in 10 number of alleles. Results obtained from the control and
mm Tris-HCl, 1 mm ethylenediaminetetraacetic acid test groups were compared using the x2 test to show
(EDTA), pH 8.0, and the concentration was measured statistical significance. In each group, the observed distri-
bution of homozygotes and heterozygotes group con-by spectrophotometry.
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Table 1. Genotype distribution and allele frequency of the GLUT1 gene in NIDDM with or without nephropathy
Genotype Allele frequency
N XbaI(1/1) XbaI(2/1) XbaI(2/2) XbaI(1) XbaI(2)
NIDDM 131 43(0.33) 78(0.59)d 10(0.08) 164(0.63) 98(0.37)d
DN(1) 64 12(0.19) 48(0.75)ab 4(0.06) 72(0.56) 56(0.44)ac
DN(2) 45 22(0.49) 20(0.44) 3(0.07) 64(0.71) 26(0.29)
Controls 124 77(0.62) 41(0.33) 6(0.05) 195(0.79) 53(0.21)
a P , 0.001 vs Control
b P , 0.01 vs DN(2)
c P , 0.05 vs DN(2)
d P , 0.01 vs Control
Table 2. Baseline characteristics of the NIDDM patients according to GLUT1
Genotype
XbaI(1/1) XbaI(1/2) XbaI(2/2)
N 5 43 N 5 78 N 5 10
Gender male/female 17/26 27/51 4/8
Age years 60.7612.0 58.4613.3 59.5612.4
History of diabetes years 9.867.6 8.567.0 9.968.5
Systolic BP mm Hg 145.864.0 142.563.5 146.863.0
Diastolic BP mm Hg 85.662.0 83.461.4 85.961.5
Glycosolated hemoglobin % 7.561.2 7.361.1 7.461.4
BMI kg/m2 26.263.6 25.466.6 24.965.0
formed to expectation based on the Hardy–Weinberg cases of NIDDM were categorized according to their
genotype. Baseline characteristics were compared overequilibrium analysis. Odds ratios and their correspond-
ing confidence intervals were then calculated from the the three genotypes (Table 2). Table 2 shows that these
baseline characteristics were similar for the three differ-logistic regression parameter estimates. A P of less than
0.05 was regarded as statistically significant. ent genotypes.
To examine the influence of GLUT1 gene polymor-
phism on the development of retinopathy complication
RESULTS
and its correlation with DN in NIDDM patients, 45 pa-
The distribution of the GLUT1 gene polymorphism tients with proliferative retinopathy were divided into
in 131 NIDDM patients and those with or without ne- two groups according to whether they were complicated
phropathy is shown in Table 1. Twenty-two out of 131 with DN (Table 3). The genotype distribution of GLUT1
NIDDM patients who did not have the qualified record showed that there was a significant difference between
of a 24-hour UAE were excluded from the study of the group of retinopathy patients with DN and the nor-
comparison between diabetics with or without nephropa- mal subjects. However, there was no difference between
thy. The frequency of XbaI (1/2) genotype in DN was the retinopathy patients without DN and the normal
much higher (75 vs. 44%, P , 0.01), whereas the XbaI subjects.
(1/1) genotype was apparently lower (19 vs. 49%, P ,
0.01) than the group of NIDDM patients without ne-
DISCUSSIONphropathy. The allele frequency of XbaI (2) was also
significantly higher in the former group than the latter Among all of the long-term complications of diabetes,
nephropathy imposes the highest social and economicone (44 vs. 29%, P , 0.05). It is important to point out
that the distribution of GLUT1 genotype frequency for burden. DN, which progresses inexorably toward renal
failure, is a common indication for hemodialysis andthe NIDDM patients without nephropathy showed no
substantial difference to that of the normal controls. renal transplantation. In addition, DN and its related
metabolic alterations accelerate the progression of ath-Therefore, the presence of the XbaI (2) allele virtually
had a strong association with the development of DN erosclerotic lesions, further increasing the already ex-
isting high risk of coronary artery disease. Although mul-instead of the NIDDM per se. The odds ratio was 1.915,
and the 95% confidence interval was 1.044 to 3.514. tiple factors contribute to the initiation and progression
of DN, hyperglycemia and genetic predisposition are theTo assess the relationship of GLUT1 genotype and
the baseline characteristics of the NIDDM patients, 131 two major components implicated in the development
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Table 3. Relationship between the GLUT1 genotype and diabetic retinopathy in NIDDM patients
Genotype Allele frequency
N XbaI(1/1) XbaI(1/2) XbaI(2/2) XbaI(1) XbaI(2)
Retinopathy DN(1) 37 10(0.27)b 22(0.59)b 5(0.14)a 42(0.56)b 32(0.43)b
Retinopathy DN(2) 8 3(0.37) 4(0.50) 1(0.13) 10(0.62) 6(0.38)
Controls 124 77(0.62) 41(0.33) 6(0.05) 195(0.79) 53(0.21)
a P , 0.05 vs. Controls
b P , 0.01 vs. Controls
of DN [17]. It has been noted that only a limited number cells also express functional GLUT1 in culture (abstract;
Liu et al, J Am Soc Nephrol 9:636A, 1998). Interestingly,of diabetic patients experience DN. The prevalence of
DN is considered to be approximately 40% in both types it has been reported that cultured rat mesangial cells
transduced with the human GLUT1 gene demonstratedof diabetes, but there is a wide variation among different
ethnic groups [17]. A long-term study of diabetic patients a markedly increased glucose uptake and metabolism
as well as significant stimulation of extracellular matrixwho received kidney transplants because of the develop-
ment of end-stage renal disease caused by DN showed synthesis, even when the cells were grown in a normal
extracellular glucose concentration [26]. This work sug-that only approximately 50% of the patients had a recur-
rence of nephropathy during a post-transplantation pe- gests that increased glucose uptake, rather than the ex-
tracellular concentration of glucose per se, would be ariod of 6 to 14 years. This suggested that there might
be a difference in the donor kidney’s resistance to the major metabolic determinant in the development of mes-
angial expansion and glomerulosclerosis in diabetics. Itdevelopment of DN [18]. In diabetes, an obvious injuri-
ous impact on the host cells is the continued presence is plausible that the expression and activity of mesangial
GLUT1 in diabetic patients varies according to theirof an abnormally high concentration of extracellular glu-
cose. Nonetheless, there is also evidence suggesting that genetic background, and this variation could explain why
only a limited group of diabetic patients are predisposedthe mere presence of high blood glucose level is not
sufficient to cause the development of DN [19]. Observa- to the development of renal disease, and could also clar-
ify the reason for the poor correlation between glycemictions of familial clustering of renal complications and
the fact that the incidence of DN varied in different levels and progression of nephropathy in a subset of
diabetics. Based on these assumptions, GLUT1 was cho-racial groups suggest that genetic background may be the
most important determinant in the causation of diabetic sen as a candidate gene for the study of polymorphism
in our investigation.renal damage. It is therefore hypothesized that the inves-
tigation of genetic susceptibility to DN will shed light The evidence shows that the XbaI (1/2) genotype
and XbaI (–) allele frequency were significantly higheron the pathogenesis of renal involvement in diabetes.
The renal glomerular lesions of human and experi- in NIDDM patients with DN as compared with either
normal subjects or NIDDM patients without DN. Themental diabetes mellitus are characterized by glomerular
hypertrophy and the deposition of extracellular matrix absence of an association between the XbaI (2/2) geno-
type and DN probably is due to the relatively low fre-in the form of diffuse thickening of the glomerular base-
ment membrane and mesangial expansion [20, 21]. In quency of XbaI (2/2) genotype and the small number
of investigated subjects. Our investigation suggests thatvitro study proved that the mesangial cells increased
their production of extracellular matrix when incubated the GLUT1 polymorphism may be an important genetic
marker for the development of DN in NIDDM of Chi-in medium with a high concentration of glucose [22, 23].
It is conceivable that the metabolic derangement of renal nese patients. NIDDM patients with the XbaI (2) allele
are more likely to develop DN as compared with patientscells, particularly mesangium, resulting in the excessive
formation and deposition of extracellular matrix compo- without the XbaI (2) allele. Previous studies from the
literature on the relationship of GLUT1 gene polymor-nent in diabetes is a likely determinant of mesangial
expansion and glomerulosclerosis. Accordingly, the reg- phism and NIDDM yield contradictory results. Elbein
et al, who examined the linkage of the GLUT1 genotypeulation of glucose transporter-mediated mesangial glu-
cose uptake might be crucial in order to understand the with NIDDM in 18 large Utah white pedigrees, failed
to find a genetic predisposition [5]. On the other hand,pathophysiology of DN. GLUT1 is the main glucose
transporter in the glomeruli. Previous studies demon- Tao et al, in an analysis of 91 Japanese NIDDM patients
and 87 nondiabetic control subjects, found that the XbaIstrated that rat mesangial cell expressed GLUT1 and
GLUT4 [24, 25]. Recently, to our knowledge for the first (2) allele of the GLUT1 gene appeared to be a genetic
marker of NIDDM in their subjects [6]. Of course, thistime, our in vitro work proved that human mesangial
Liu et al: GLUT1 and diabetic nephropathy 1847
controversy might be due to racial differences. Results prospective and long-term investigations are needed to
provide definitive answers. Of course, there are multipleobtained from the Japanese may be different from those
coming from the Caucasians. However, another reason- genetic factors influencing the development and out-
come of diabetic nephropathy. GLUT1 gene polymor-able explanation for this contradiction may be because
these investigations did not pay special attention to the phism may be one of them that is found to be meaningful
renal involvement of the NIDDM cases in their study in its pathogenesis.
populations. As shown in our data (Table 1), there was
also a close association between XbaI (2) allele of ACKNOWLEDGMENTS
GLUT1 and 131 NIDDM cases in general, but when we This work was supported in part by a grant from the National
further dissected the result by dividing the investigated Natural Science Foundation of China (39870288).
cases into two categories according to their absence or
Reprint requests to Lei-Shi Li, M.D., Research Institute of Nephrol-presence of renal complication, it was fascinating to find ogy, Jinling Hospital, 305 East Zhong Shan Road, Nanjing 210002,
out that there were actually no significant differences People’s Republic of China.
E-mail: LSli1226@public1.ptt.js.cnbetween those NIDDM patients without DN and the
normal subjects, as far as their genotype or allele fre-
REFERENCESquency of the GLUT1 gene was concerned. The positive
association of XbaI (2) allele for the NIDDM cases in 1. Li LS: End-stage renal diseases in China. Kidney Int 49:287–301,
1996general is due to a skewed population, which includes a
2. Fogarty DG, Krolewski AS: Genetic susceptibility and the rolelarge number of DN patients who happened to be in a of hypertension in diabetic nephropathy. Curr Opin Nephrol Hy-
clinic mainly serving the renal patients. On the other pertens 6:184–191, 1997
3. Doria A, Warram JH, Krolewski AS: Genetic susceptibility tohand, the presence of the XbaI (2) allele also in part
nephropathy in insulin dependent diabetes: From epidemiology toof the diabetics without nephropathy points to the possi-
molecular genetics. Diabetes Metab Rev 11:287–314, 1995
bility that the XbaI (2) allele may be only one of the 4. Parving H-H, Tarnow L, Rossing P: Genetic of diabetic nephrop-
athy. J Am Soc Nephrol 7:2509–2517, 1996multiple risk factors for the development of DN. It is
5. Elbein SC, Hoffman MD, Matsutani A, Permutt MA: Linkageimaginable that the pathogenesis of a complex renal com-
analysis of GLUT1 (Hep G2) and GLUT2 (liver/islet) genes in
plication such as DN has multiple inducing factors. It is familial NIDDM. Diabetes 41:1660–1667, 1992
6. Tao T, Tanizawa Y, Matsutani A, Matsubara A, Kanek T,also possible that the XbaI (2) allele does not function
Kaku K: Hep G2/erythrocyte glucose transporter (GLUT1) genesimply as a diabetes-independent risk factor for nephrop-
in NIDDM: A population association study and molecular scanning
athy. in Japanese subjects. Diabetologia 38:942–947, 1995
7. O’Rahilly S, Choi WH, Patel P, Turner RC, Flier JA, MollerGenerally, the complications of diabetic mellitus mani-
DE: Detection of mutation in insulin-receptor gene in NIDDMfest in a constellation. However, the annual and cumula-
patients by analysis of single-stranded conformation polymor-
tive incidences of DN, diabetic retinopathy, and neurop- phism. Diabetes 40:777–782, 1991
athy are different [27]. For instance, it has been reported 8. Undlien DE, Bennett ST, Todd JA, Akselsen HE, Knip M,
Thorsby E, Ronningen KS: Insulin gene region-encoded suscepti-that among diabetics developing diabetic retinopathy,
bility to NIDDM maps upstream of the insulin gene. Diabetes61% already had diabetic neuropathy, but only 24% 44:620–625, 1995
had DN [28]. These data suggest that the occurrence of 9. Celi FS, Silver K, Walston J, Knowler WC, Bogardas C, Shul-
diner AR: Lack of IRS-1 codon 513 and 972 polymorphism inophthalmic and renal complications of diabetes may be
Pima Indians. J Clin Endocrinol Metab 80:2827–2829, 1995influenced by organ-specific pathogenetic factors in addi- 10. Yoshimura R, Araki E, Ura S, Todaka M, Tsuruzoe K, Furukwa
tion to their common pathogenesis. The results of our N, Motoshima H, Yoshizato K, Kaneko K, Kishikawa H, Shichiri
M: Impact of natural IRS-1 mutation on insulin signal: Mutationsstudy with regards to the GLUT1 gene polymorphism
of IRS-1 in the PTB domain and near SH2 protein binding sitesin diabetic retinopathy support this concept. The distri- result in impaired function at deferent steps of IRS-1 signaling.
bution of GLUT1 gene polymorphism in these cases did Diabetes 46:929–936, 1997
11. Permutt MA, Chiu KC, Tanizawa Y: Glucokinase and NIDDM:not show a strong association with retinopathy. It is also
A candidate gene that paid off. Diabetes 41:1367–1372, 1992evidence indicating that the close association of XbaI 12. Baldwin SA: Mammalian passive glucose transporters: Members
(2) allele in NIDDM is mainly a gene marker for DN of an ubiquitous family of active and passive transport protein.
Biochem Biophys Acta 1154:17–49, 1993patients.
13. Klip A, Tsakiridis T, Marette A, Ortiz PA: Regulation of expres-Our investigation demonstrates that NIDDM patients
sion of glucose transporters by glucose: A review of studies in vivo
with the XbaI (2) allele of the GLUT1 gene may be and in cell cultures. FASEB J 8:43–53, 1994
14. Debnam ES, Unwin RJ: Hyperglycemia and intestinal and renalprone to develop DN in Chinese subjects. This genetic
glucose transporter: Implications for diabetic renal injury. Kidneysusceptibility presumably functioning as a risk factor in
Int 50:1101–1109, 1996
conjunction with other factors of diabetes yields a higher 15. Heilig C, Zaloga C, Lee M, Zhao X, Riser B, Brosius F, Cortes
P: Immunogold localization of high-affinity glucose transporterincidence of nephropathy. Is this gene polymorphism of
isoform in normal rat kidney. Lab Invest 73:674–684, 1995GLUT1 also able to influence the progression of DN
16. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig
and its clinical course? Our study is unable to answer KO, Zhu M, Concepcion LA, Brosius FC III: D-glucose stimulates
mesangial cell GLUT1 expression and basal and IGF-1 sensitivethese questions, as a large sample population and both
Liu et al: GLUT1 and diabetic nephropathy1848
glucose uptake in rat mesangial cells: Implications for diabetic 23. Ayo S, Radnik R, Garoni J, Glss W, Kreisberg J: High glucose
causes an increase in extracellular matrix proteins in cultured mes-nephropathy. Diabetes 46:1030–1039, 1997
17. Parving HH, Osterby R, Anderson PW, Hsueh W: Diabetic angial cells. Am J Pathol 136:1339–1348, 1990
24. Heilig CW, Brosius FC III, Henry DN: Glucose transportersnephropathy, in The Kidney (5th ed), edited by Brenner BM,
Philadelphia, W.B. Saunders, 1996, pp 1864–1892 of the glomerulus and the implications for diabetic nephropathy.
Kidney Int 52:S91–S99, 199718. Mauer SM, Goetz FC, McHugh LE: Long-term study of normal
kidney transplanted into patients with type I diabetes. Diabetes 25. Wakisaka M, He Q, Spiro MJ, Spiro RG: Glucose entry into rat
mesangial cells is mediated by both Na1-coupled and facilitative38:516–520, 1989
19. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. transporters. Diabetologia 38:291–297, 1995
26. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M,Am J Kidney Dis 27:167–194, 1996
20. Osterby R, Parving HH, Hommel E, Jogensen HE, Lokkegaard Cortes P: Overexpression of glucose transporters in rat mesangial
cells cultured in a normal glucose milieu mimics the diabetic pheno-H: Glomerular structure and function in diabetic nephropathy:
Early to advanced stage. Diabetes 39:1057–1063, 1990 type. J Clin Invest 96:1802–1814, 1995
27. Mauer M, Mogensen CE, Friedman EA: Diabetic nephropathy,21. Fioretto P, Steffes MW, Mauer SM: Glomerular structure in
nonproteinuric IDDM patients with various levels of albuminuria. in Diseases of the Kidney (6th ed), edited by Schrier RW,
Gottschalk CW, Boston, Little Brown and Company, 1997, ppDiabetes 43:1358–1364, 1994
22. Ayo S, Radnik R, Glass W, Garoni J, Ranyst E, Kreisberg J: 2019–2061
28. Marre M: Genetics and diabetic nephropathy, in The Kidney andIncreased extracellular matrix synthesis and mRNA in mesangial
cells grown in high glucose medium. Am J Physiol 260:F185–F191, Hypertension in Diabetes Mellitus (3rd ed), edited by Mogensen
CE, Basle, Kluwer Academic, 1997, pp 45–521991
